Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

20 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Multiple Myeloma and Plasma Cell Neoplasm NCT01169337 Transmittal - E3A06 Source Document Tracking Coversheet - 3086867v1.0 - E3A06 Source Document Tracking Coversheet

- 8/1/15 - 1 formulario, 4 itemgroups, 15 items, 1 idioma
Itemgroups: Header, On Treatment or Observation Report Period, Off Treatment or Off Observation Report Period, Document Type
E3A06 Source Document Tracking Coversheet Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=86D0D05F-CCF7-87DB-E040-BB89AD4374EF

Multiple Myeloma and Plasma Cell Neoplasm NCT00602641 Transmittal - E1A06 Source Document Tracking Coversheet - 2703636v1.0 - E1A06 Source Document Tracking Coversheet

- 8/1/15 - 1 formulario, 4 itemgroups, 16 items, 1 idioma
Itemgroups: Header, ON TREATMENT, OFF TREATMENT, Document Type
E1A06 Source Document Tracking Coversheet Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4003E839-33CA-0374-E044-0003BA3F9857

Multiple Myeloma and Plasma Cell Neoplasm NCT01078454 Transmittal - E4A08 SOURCE DOCUMENT TRACKING COVERSHEET - 2972557v1.0 - E4A08 SOURCE DOCUMENT TRACKING COVERSHEET

- 8/1/15 - 1 formulario, 4 itemgroups, 16 items, 1 idioma
Itemgroups: Header, Reporting Period, OFF TREATMENT, Document Type
E4A08 SOURCE DOCUMENT TRACKING COVERSHEET Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7BCCA614-536C-15BB-E040-BB89AD4326D3

Multiple Myeloma and Plasma Cell Neoplasm NCT00522392 Transmittal - E1A05 Source Document Tracking Coversheet - Form 2857 - 2648777v1.0 - E1A05 Source Document Tracking Coversheet - Form 2857

- 8/1/15 - 1 formulario, 4 itemgroups, 15 items, 1 idioma
Itemgroups: Header, ON TREATMENT, OFF TREATMENT, Document Type
E1A05 Source Document Tracking Coversheet - Form 2857 Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3256D4E6-6819-6708-E044-0003BA3F9857

Leukemia NCT01041703 Flow Sheet - E2906 Source Document Tracking Coversheet Form - 2947795v1.0 - E2906 Source Document Tracking Coversheet Form

- 8/1/15 - 1 formulario, 5 itemgroups, 14 items, 1 idioma
Itemgroups: Header Module, Header, Reporting Period, Off Treatment Report Period, Document Information
E2906 Source Document Tracking Coversheet Form Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=74BCE806-5876-4D7A-E040-BB89AD437934

Lung Cancer NCT01107626 Flow Sheet - E5508 Source Document Tracking Coversheet Form - 2908022v1.0 - E5508 Source Document Tracking Coversheet Form

- 9/1/15 - 1 formulario, 3 itemgroups, 13 items, 1 idioma
Itemgroups: Header Module, Header, Document Information
E5508 Source Document Tracking Coversheet Form Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6D435D37-53F7-AA13-E040-BB89AD43538D

E5202 Source Document Tracking Coversheet NCT00217737 - E5202 Source Document Tracking Coversheet NCT00217737

- 16/6/15 - 1 formulario, 3 itemgroups, 14 items, 1 idioma
Itemgroups: Header, Patient demographics, Footer module
E5202 Source Document Tracking Coversheet NCT00217737 Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=852743C1-364D-5F08-E040-BB89AD431700

E1208 Source Document Tracking Coversheet NCT01004978

- 8/6/15 - 1 formulario, 1 itemgroup, 12 items, 1 idioma
Itemgroup: ECOG clinical trial administrative data
E1208 Source Document Tracking Coversheet NCT01004978 Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6FDC3F1E-42D2-1043-E040-BB89AD430FD1

ECOG-E1505 Source Document Tracking Cover Sheet NCT00324805

- 16/6/15 - 1 formulario, 3 itemgroups, 14 items, 1 idioma
Itemgroups: Header, Patient demographics, Footer module
ECOG-E1505 Source Document Tracking Cover Sheet NCT00324805 Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=080E4673-1BE3-69B1-E044-0003BA3F9857

E2905 Source Document Tracking Coversheet NCT00843882

- 28/7/15 - 1 formulario, 1 itemgroup, 13 items, 1 idioma
Itemgroup: ECOG clinical trial administrative data
E2905 Source Document Tracking Coversheet NCT00843882 Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0EA9D5AE-D3E2-1B14-E044-0003BA3F9857

E5204 Source Document Tracking Coversheet NCT00303628

- 16/6/15 - 1 formulario, 3 itemgroups, 15 items, 1 idioma
Itemgroups: Header, Patient demographics, Footer module
E5204 Source Document Tracking Coversheet NCT00303628 Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=08FD88A5-89D0-5626-E044-0003BA3F9857

Immunogenicity, safety and reactogenicity of combined hepatitis A / hepatitis B vaccine (TWINRIX ADULT) in healthy children (100565) - Long-Term Follow-Up (Visit 12, Year 9) - Informed Consent; Demographics; Laboratory Tests; Follow-Up Studies; Tracking Document

- 27/9/21 - 1 formulario, 7 itemgroups, 28 items, 1 idioma
Itemgroups: Administrative, Informed Consent, Demographics, Laboratory Tests, Follow-Up Studies, Tracking Document - Reason for non participation, Investigator signature
Study ID: 100565 Clinical Study ID: 100565 Study Title: An open study to evaluate the immunogenicity, safety and reactogenicity of GlaxoSmithKline Biologicals' commercially available combined hepatitis A / hepatitis B vaccine (TWINRIX ADULT) containing 720 ELISA units of hepatitis A antigen and 20 µg of hepatitis B surface antigen, administered following a two-dose (0, 6 months) schedule in healthy children between the ages of 1 and 11 years Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Phase: phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine Trade Name: Twinrix Study Indication: Hepatitis A; Hepatitis B

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial